Combinations of alpha 7 nicotinic acetylcholine receptor activators and mGluR5 antagonists for use in dopamine induced dyskinesia in Parkinson's Disease
Di Paolo, Therese,Feuerbach, Dominik,Gomez-Mancilla, Baltazar,Lopez-Lopez, Cristina,Johns, Donald,Gasparini, Fabrizio
申请号：
AU2012232711
公开号：
AU2012232711B2
申请日:
2012.03.16
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
The present invention relates to novel combinations suitable for the treatment of dyskinesia associated with dopamine agonist therapy in Parkinson's Disease, which comprise, as active ingredients, at least one low molecular weight nicotinic acetylcholine receptor alpha 7 activator and at least one low molecular weight metabotropic glutamate receptor 5 antagonist； to their preparation； to their use as medicaments and to medicaments comprising them.
